vs
BillionToOne, Inc.（BLLN）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
BillionToOne, Inc.的季度营收约是REGIS CORP的1.5倍（$83.5M vs $57.1M），BillionToOne, Inc.净利率更高（6.8% vs 0.8%，领先6.0%），BillionToOne, Inc.同比增速更快（117.4% vs 22.3%），BillionToOne, Inc.自由现金流更多（$6.5M vs $891.0K）
BillionToOne, Inc.是一家生命科学与分子诊断企业，专注研发高精度基因检测解决方案，核心产品包括无创产前检测、肿瘤诊断试剂及罕见病筛查服务，服务全球多地的医疗机构、患者及科研合作方。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
BLLN vs RGS — 直观对比
营收规模更大
BLLN
是对方的1.5倍
$57.1M
营收增速更快
BLLN
高出95.1%
22.3%
净利率更高
BLLN
高出6.0%
0.8%
自由现金流更多
BLLN
多$5.6M
$891.0K
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $83.5M | $57.1M |
| 净利润 | $5.7M | $456.0K |
| 毛利率 | 69.9% | — |
| 营业利润率 | 11.5% | 10.8% |
| 净利率 | 6.8% | 0.8% |
| 营收同比 | 117.4% | 22.3% |
| 净利润同比 | 138.3% | -94.0% |
| 每股收益（稀释后） | $0.10 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLLNRGS
| Q4 25 | — | $57.1M | ||
| Q3 25 | $83.5M | $59.0M | ||
| Q2 25 | — | $60.4M | ||
| Q1 25 | — | $57.0M | ||
| Q4 24 | — | $46.7M | ||
| Q3 24 | $38.4M | $46.1M | ||
| Q2 24 | — | $49.4M | ||
| Q1 24 | — | $49.2M |
净利润BLLNRGS
| Q4 25 | — | $456.0K | ||
| Q3 25 | $5.7M | $1.4M | ||
| Q2 25 | — | $116.5M | ||
| Q1 25 | — | $250.0K | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $-14.9M | $-853.0K | ||
| Q2 24 | — | $91.2M | ||
| Q1 24 | — | $-2.3M |
毛利率BLLNRGS
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率BLLNRGS
| Q4 25 | — | 10.8% | ||
| Q3 25 | 11.5% | 10.0% | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | — | 8.8% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | -32.9% | 4.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 8.3% |
净利率BLLNRGS
| Q4 25 | — | 0.8% | ||
| Q3 25 | 6.8% | 2.3% | ||
| Q2 25 | — | 192.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | -38.8% | -1.9% | ||
| Q2 24 | — | 184.7% | ||
| Q1 24 | — | -4.7% |
每股收益（稀释后）BLLNRGS
| Q4 25 | — | $0.16 | ||
| Q3 25 | $0.10 | $0.49 | ||
| Q2 25 | — | $43.67 | ||
| Q1 25 | — | $0.08 | ||
| Q4 24 | — | $2.71 | ||
| Q3 24 | $-1.47 | $-0.36 | ||
| Q2 24 | — | $38.40 | ||
| Q1 24 | — | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.2M | $18.4M |
| 总债务越低越好 | $55.0M | $113.3M |
| 股东权益账面价值 | $-239.5M | $188.7M |
| 总资产 | $327.5M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资BLLNRGS
| Q4 25 | — | $18.4M | ||
| Q3 25 | $195.2M | $16.6M | ||
| Q2 25 | — | $17.0M | ||
| Q1 25 | — | $13.3M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $5.9M |
总债务BLLNRGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | $55.0M | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益BLLNRGS
| Q4 25 | — | $188.7M | ||
| Q3 25 | $-239.5M | $187.6M | ||
| Q2 25 | — | $185.6M | ||
| Q1 25 | — | $68.6M | ||
| Q4 24 | — | $66.7M | ||
| Q3 24 | $-242.9M | $56.4M | ||
| Q2 24 | — | $56.8M | ||
| Q1 24 | — | $-35.8M |
总资产BLLNRGS
| Q4 25 | — | $588.3M | ||
| Q3 25 | $327.5M | $592.1M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | — | $511.2M | ||
| Q4 24 | — | $530.1M | ||
| Q3 24 | — | $508.9M | ||
| Q2 24 | — | $530.5M | ||
| Q1 24 | — | $543.7M |
负债/权益比BLLNRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $6.5M | $891.0K |
| 自由现金流率自由现金流/营收 | 7.7% | 1.6% |
| 资本支出强度资本支出/营收 | 8.8% | 1.4% |
| 现金转化率经营现金流/净利润 | 2.42× | 3.65× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势，按日历期对齐
经营现金流BLLNRGS
| Q4 25 | — | $1.7M | ||
| Q3 25 | $13.8M | $2.3M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $6.2M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $-1.3M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | — | $-277.0K |
自由现金流BLLNRGS
| Q4 25 | — | $891.0K | ||
| Q3 25 | $6.5M | $1.9M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | — | $5.9M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | — | $-326.0K |
自由现金流率BLLNRGS
| Q4 25 | — | 1.6% | ||
| Q3 25 | 7.7% | 3.2% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | -3.0% | ||
| Q2 24 | — | 10.3% | ||
| Q1 24 | — | -0.7% |
资本支出强度BLLNRGS
| Q4 25 | — | 1.4% | ||
| Q3 25 | 8.8% | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.1% |
现金转化率BLLNRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | 2.42× | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
